75 related articles for article (PubMed ID: 10751796)
21. [Factors influencing thrombin generation measured as thrombin-antithrombin complexes levels and using calibrated automated thrombogram in patients with advanced coronary artery disease].
Stepień E; Plicner D; Branicka A; Stankiewicz E; Pazdan A; Sniezek-Maciejewska M; Górkiewicz I; Kapelak B; Sadowski J
Pol Arch Med Wewn; 2007 Jul; 117(7):297-305. PubMed ID: 17966595
[TBL] [Abstract][Full Text] [Related]
22. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
[TBL] [Abstract][Full Text] [Related]
23. Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction.
Nilsen DW; Gøransson L; Larsen AI; Hetland O; Kierulf P
Thromb Haemost; 1997 Jan; 77(1):57-61. PubMed ID: 9031450
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of iloprost (ZK36374) versus aspirin in preventing heparin-induced platelet activation during cardiac operations.
Kappa JR; Horn MK; Fisher CA; Cottrell ED; Ellison N; Addonizio VP
J Thorac Cardiovasc Surg; 1987 Sep; 94(3):405-13. PubMed ID: 2442566
[TBL] [Abstract][Full Text] [Related]
25. Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment.
Kyrle PA; Brockmeier J; Weltermann A; Eichinger S; Speiser W; Lechner K; Eichler HG
Thromb Haemost; 1997 Apr; 77(4):685-9. PubMed ID: 9134643
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects.
Rodés-Cabau J; Palacios A; Palacio C; Girona J; Galve E; Evangelista A; Casaldáliga J; Albert D; Picó M; Soler-Soler J
Int J Cardiol; 2005 Jan; 98(1):107-12. PubMed ID: 15676174
[TBL] [Abstract][Full Text] [Related]
27. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
Brister SJ; Ofosu FA; Buchanan MR
Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
[TBL] [Abstract][Full Text] [Related]
28. Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease.
Pettersen AÅ; Arnesen H; Opstad TB; Bratseth V; Seljeflot I
Thromb Res; 2012 Sep; 130(3):424-8. PubMed ID: 22795340
[TBL] [Abstract][Full Text] [Related]
29. In vivo platelet release in myeloproliferative disorders.
Ireland H; Lane DA; Wolff S; Foadi M
Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
[TBL] [Abstract][Full Text] [Related]
30. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
31. Rational approach to use of heparin during cardiac catheterization in children.
Grady RM; Eisenberg PR; Bridges ND
J Am Coll Cardiol; 1995 Mar; 25(3):725-9. PubMed ID: 7860920
[TBL] [Abstract][Full Text] [Related]
32. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
33. Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
J Vasc Surg; 2005 Aug; 42(2):252-8. PubMed ID: 16102623
[TBL] [Abstract][Full Text] [Related]
34. Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.
Chilver-Stainer L; Lämmle B; Alberio L
Thromb Haemost; 2004 Feb; 91(2):276-82. PubMed ID: 14961154
[TBL] [Abstract][Full Text] [Related]
35. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
36. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
[TBL] [Abstract][Full Text] [Related]
37. Thrombin generation during collection and storage of blood.
Skjønsberg OH; Kierulf P; Fagerhol MK; Godal HC
Vox Sang; 1986; 50(1):33-7. PubMed ID: 3953021
[TBL] [Abstract][Full Text] [Related]
38. Cardiac catheterization: haemostatic changes in pediatric versus adult patients.
Hoerl G; Tafeit E; Leschnik B; Wagner T; Muntean W; Juergens G; Koestenberger M; Cvirn G
J Thromb Thrombolysis; 2011 Oct; 32(3):372-7. PubMed ID: 21667202
[TBL] [Abstract][Full Text] [Related]
39. Platelet and Thrombin Activity Following Cardiac Catheterization Despite Treatment with Aspirin.
Andreotti F; Lefroy DC; Sciahbasi A; Crake T; Maseri A; Marco E; Davies GJ
J Thromb Thrombolysis; 1998 Sep; 6(2):141-145. PubMed ID: 10751796
[TBL] [Abstract][Full Text] [Related]
40. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
